You are here

Director/PDMR Shareholding

DXS INTERNATIONAL PLC

Directors' Dealing

The Board of DXS International plc (the “Company”), the NEX quoted clinical decision support developer and supplier of clinical decision support systems is pleased to confirm that it has been notified that the CEO, David Immelman and Bob Sutcliffe, the Chairman, have purchased on 18th and 19th October a total of 120,538 Ordinary Shares at the following prices:

Date of tradeDirectorNumber of SharesPrice per share
18th OctoberDavid Immelman20,5388.660p
19th OctoberBob Sutcliffe100,0008.515p

Following the transactions specified above Mr Immelman now holds 3,637,737 Ordinary Shares representing 10.34% of the issued share capital of the Company and Mr Sutcliffe holds 437,691 Ordinary Shares representing 0.96% of the issued share capital of the Company.

The Directors of DXS International plc accept responsibility for this announcement

Enquiries:

David Immelman   (Chief Executive)
DXS International plc
01252 719800
david@dxs-systems.com
Wrecclesham House
Wrecclesham Road
Farnham
Surrey
GU10 4PS
 
www.dxs-systems.co.uk 


David Papworth
City & Merchant
0207 101 7676
info@cityandmerchant.com
Level 17, Dashwood House
69 Old Broad Street,
London
EC2M 1QS
 

Note to Editors:

DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively which should significantly contribute towards the NHS achieving its projected efficiency savings.

Monday, October 22, 2018 - 02:00